These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3383867)

  • 1. The effect of sotalol on exercise-induced ventricular arrhythmias.
    Petzl DH; Probst P; Glogar D; Schuster E
    Eur Heart J; 1988 Mar; 9(3):265-70. PubMed ID: 3383867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term sotalol therapy in patients with ventricular arrhythmias.
    Mary-Rabine L; Soumagne D; Stiels B
    Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration/response relations for the multiple antiarrhythmic actions of sotalol.
    Woosley RL; Barbey JT; Wang T; Funck-Brentano C
    Am J Cardiol; 1990 Jan; 65(2):22A-27A; discussion 35A-36A. PubMed ID: 2294688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac arrhythmia in moderate arterial hypertension. Epidemiologic survey of 251 cases. Effect of sotalol].
    Clémenty J; Safar M; Vrancea F
    Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):47-51. PubMed ID: 2648967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of d-sotalol, a pure class III antiarrhythmic compound, in patients with symptomatic complex ventricular ectopy. Results of a multicenter, randomized, double-blind, placebo-controlled dose-finding study. The d-Sotalol PVC Study Group.
    Hohnloser SH; Meinertz T; Stubbs P; Crijns HJ; Blanc JJ; Rizzon P; Cheuvart B
    Circulation; 1995 Sep; 92(6):1517-25. PubMed ID: 7664435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of azimilide and d,l-sotalol on the heart rate and blood pressure response to isoproterenol in anesthetized rats.
    Mittelstadt SW; Maynard AE; Benn DR; Lowe ER; Kostreva DR
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):591-8. PubMed ID: 9358964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity.
    Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J
    Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of d, I sotalol for suppression of chronic ventricular arrhythmias.
    Anastasiou-Nana MI; Gilbert EM; Miller RH; Singh S; Freedman RA; Keefe DL; Saksena S; MacNeil DJ; Anderson JL
    Am J Cardiol; 1991 Mar; 67(6):511-6. PubMed ID: 1705386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter trial of sotalol for suppression of frequent, complex ventricular arrhythmias: a double-blind, randomized, placebo-controlled evaluation of two doses.
    Anderson JL; Askins JC; Gilbert EM; Miller RH; Keefe DL; Somberg JC; Freedman RA; Haft LR; Mason JW; Lessem JN
    J Am Coll Cardiol; 1986 Oct; 8(4):752-62. PubMed ID: 2428852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term antiarrhythmic and hemodynamic effects of d,l-sotalol in patients with symptomatic ventricular arrhythmias.
    Hohnloser SH; Zabel M; Krause T; Just H
    Am Heart J; 1992 May; 123(5):1220-4. PubMed ID: 1575137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term sotalol therapy in patients with arrhythmias.
    Simon A; Berman E
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):547-56. PubMed ID: 385638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.
    Fitton A; Sorkin EM
    Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of antiarrhythmic efficacy of sotalol in various doses in patients with ventricular tachyarrhythmias].
    Luczak D; Dabrowski R; Szwed H; Gasior Z; Stanke A; Jasek S; Skrabucha B; Matar A; Kowalik I
    Pol Merkur Lekarski; 1997 Feb; 2(8):122-5. PubMed ID: 9538657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with sotalol in the treatment of cardiac arrhythmias.
    Kirschenbaum HL; Rosenberg JM
    Clin Ther; 1994; 16(3):346-64. PubMed ID: 7923303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sotalol on arrhythmias and exercise tolerance in patients with hypertrophic cardiomyopathy.
    Tendera M; Wycisk A; Schneeweiss A; Poloński L; Wodniecki J
    Cardiology; 1993; 82(5):335-42. PubMed ID: 8374931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of sotalol in suppressing ventricular ectopic beats.
    Myburgh DP; Goldman aP; Cartoon J; Schamroth JM
    S Afr Med J; 1979 Aug; 56(8):295-8. PubMed ID: 399099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sotalol: a new beta-adrenergic blocker for ventricular arrhythmias.
    Cavusoglu E; Frishman WH
    Prog Cardiovasc Dis; 1995; 37(6):423-40. PubMed ID: 7777671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral sotalol on systemic hemodynamics and programmed electrical stimulation in patients with ventricular arrhythmias and structural heart disease.
    Winters SL; Kukin M; Pe E; Stewart D; Deitchman D; Gomes JA
    Am J Cardiol; 1993 Aug; 72(4):38A-43A. PubMed ID: 8346725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.